Company / Return on Assets (ROA)
Tyra Biosciences, Inc. Return on Assets (ROA) History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-23.8%
FY2024
5-year range
-58.3% / -8.6%
FY2020-FY2024
Trend
+22.3%
vs FY2023
Sector context
#110 of 213
Health Care
What the data says
At -23.8%, Tyra Biosciences, Inc.'s return on assets (roa) ranks #110 of 213 in the Health Care sector. Return on Assets (ROA) returned to growth in FY2024 after 2 years of decline, reaching -23.8%.
Based on SEC 10-K filings.
-23.8% in FY2024 with a 3-year CAGR of -15.2%.
Declined from -20.8% to -23.8% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -15.2pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#110 of 213 in Health CareTop 52% of 213This company -23.8% Sector average -24.1%
▼
+1.4% above sector average
Key checks
Key Insights
- In FY2024, return on assets (roa) increased 22.3% year-over-year.
- Currently 0.3pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2021.
- Lowest return on assets (roa) in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 6.83 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -23.8% | +22.3% |
| FY2023 | -30.6% | -47.3% |
| FY2022 | -20.8% | -142.5% |
| FY2021 | -8.6% | +85.3% |
| FY2020 | -58.3% | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026